Furthermore, XRCC3 promoter methylation levels were lower in normal adjacent tissue comparing to tumor tissue (p = 0.002), whereas RAD51B promoter methylation levels were higher in tumor samples, although not reaching statistical significance (p = 0.968) (Figure 2). Here, XRCC3 is linked to neoplasm.